Becton, Dickinson and Company – I Have Added to My Position
Becton, Dickinson and Company (BDX) released Q1 2020 results on February 6th in which FY2020 guidance was lowered because of challenges experienced with its Alaris Infusion product. BDX's share price took a hit following the release of Q1 results and I acquired additional shares. Regrettably I was unable to provide a timely update since I [...]